Mr. Dershem serves as the Chief Executive Officer of MAPay, LLC. Mr. Dershem is a seasoned business development entrepreneur who has assisted multiple ventures, attracted millions of dollars of capital, and has an outstanding track record in strategic business planning and development, capital and financial sourcing, multi-disciplinary problem solving, and technology development. He also has a strong technology-transfer background from government and university research to private sector commercialization. Mr. Dershem began his ‘serial entrepreneur’ career over twenty years ago. His first foray was as co-owner of RX Returns, which grew to become the largest pharmaceutical returns company in the nation. He later helped form a niche banking company, which became one of the fastest growing private companies in New Jersey. Serving as founding CEO of Pharmasset, an Emory University start-up company, Mr. Dershem successfully raised over $25 million in private equity funding and executed a $30 million research and development agreement with DuPont. The company has subsequently gone public and was acquired by Gilead Sciences for $11 Billion. Mr. Dershem graduated with a BA in Economics from Dickinson College and holds an MBA as well.